AMLYFEND (registration number 5158583) is a United States trademark of DAIICHI SANKYO COMPANY, LIMITED. The goods and services are: Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease . The correspondent is TANIYAMA Takashi.
This trademark was filed on February 25, 2016 as United States Trademark Application Serial Number 79195206.
Trademark PTO Status
20220703 – NEW REPRESENTATIVE AT IB RECEIVED
20170505 – NOTIFICATION PROCESSED BY IB
20170414 – FINAL DISPOSITION NOTICE SENT TO IB
20170414 – FINAL DISPOSITION PROCESSED
20170413 – GRANT OF PROTECTION CREATED, TO BE SENT TO IB
20170314 – REGISTERED-PRINCIPAL REGISTER
20161227 – PUBLISHED FOR OPPOSITION
20161207 – NOTICE OF PUBLICATION
Ownership History
DAIICHI SANKYO COMPANY, LIMITED
DAIICHI SANKYO COMPANY, LIMITED
DAIICHI SANKYO COMPANY, LIMITED
File a Trademark
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.